Tag: FDA exclusivity
Patent Exclusivity vs Market Exclusivity: What’s the Real Difference for Drug Prices?
Patent exclusivity and market exclusivity are two different legal tools that protect new drugs. One comes from the patent office, the other from the FDA. Understanding the difference explains why drug prices stay high-and who controls when generics arrive.
read morerecent posts
FeNO testing measures airway inflammation in asthma by detecting nitric oxide in exhaled breath. It helps doctors confirm diagnosis, adjust treatment, and reduce flare-ups with objective, non-invasive data.
Published ON: 14 JanPatent expiry means cheaper drugs-but only if you're prepared. Learn how patients and healthcare systems can save money and avoid disruptions when brand-name drugs go generic.
Published ON: 12 JanLearn what lab tests are actually needed when taking statins, when to worry about liver or muscle side effects, and why routine testing may do more harm than good. Evidence-based guidance for safe, effective use.
Published ON: 1 JanCulture shapes how people accept even the most generic products - from medicines to apps. Understanding cultural dimensions like uncertainty avoidance and collectivism can double adoption rates and build real trust.
Published ON: 3 JanTurmeric and curcumin supplements can dangerously increase bleeding risk when taken with blood thinners like warfarin or aspirin. Real cases show INR levels spiking to life-threatening levels. Avoid combining them without medical supervision.
Published ON: 19 Jan